Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality
Aaltonen, H.; Kilkku, O.; Heinonen, E.; Mäki-Ikola, O.
Bmj 317(7172): 1586-1587
1998
ISSN/ISBN: 0959-8138 PMID: 9890764 Document Number: 497559
Document emailed within 1 workday
Related Documents
Counsell, C. 1998: Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Formal systematic review of data on patients in all relevant trials is required Bmj 317(7172): 1586Goulley, F.; Wolmark, Y.; Bourdeix, I.; Chaumet-Riffaud, P.D. 1993: Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms Therapie 48(3): 233-238
Csanda, E.; Tárczy, M. 1987: Selegiline in the early and late phases of Parkinson's disease Journal of Neural Transmission. Supplementum 25: 105-113
Dixit, S.N.; Behari, M.; Ahuja, G.K. 1999: Effect of selegiline on cognitive functions in Parkinson's disease Journal of the Association of Physicians of India 47(8): 784-786
Fiszer, U. 1989: Study of the immunologic status of persons with Parkinson disease with special reference to the effect of levodopa treatment. Preliminary report Neurologia i Neurochirurgia Polska 23(1): 7-11
Szczudlik, A.; Rudzińska, M. 2007: Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes Neurologia i Neurochirurgia Polska 41(2 Suppl 1: S6-S9
Białecka, M.; Adamiak, U.; Gawrońska-Szklarz, B. 2009: Optimisation of treatment of Parkinson's disease with levodopa Neurologia i Neurochirurgia Polska 43(5): 446-459
Larsen, J.P.; Nessler, E.G.; Hestnes, A.; Vilming, S.; Holmsen, R.; Aksnes, V.; Johnson, S.; Brodtkorb, E.; Hunstad, N.A.; Helle, J.R. 1991: Treatment of Parkinson disease with levodopa depot preparations Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(26): 3163-3166
Cernibori 1970: Electrophysiological effect of Levodopa on the phenomena of spinal inhibition and facilitation in Parkinson's disease Rivista di Neurologia 40(5): 303-309
Stern, P.H.; McDowell, F.; Miller, J.M.; Robinson, M. 1970: Levodopa and physical therapy in treatment of patients with Parkinson's disease Archives of Physical Medicine and Rehabilitation 51(5): 273-277
Sweet, R.D.; Lee, J.E.; McDowell, F. 1971: Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease Transactions of the American Neurological Association 96: 59-65
Molina, J.A.; Jiménez-Jiménez, F.J.; Ortí-Pareja, M. 1999: Motor and mental complications in the long-term treatment of complicated Parkinson's disease with levodopa Revista de Neurologia 28(10): 982-990
Sage, J.I.; Trooskin, S.; Sonsalla, P.K.; Heikkila, R.E. 1989: Experience with continuous enteral levodopa infusions in the treatment of 9 patients with advanced Parkinson's disease Neurology 39(11 Suppl 2: 60
Timofeeva, A.A. 2014: Treatment for advanced Parkinson's disease with intestinal levodopa/carbidopa gel: review of efficacy and safety Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(11): 145-151
Fernandez-Pajarin, G.; Ares-Pensado, B.; Sesar, A.; Iglesias-Canle, J.; Masa-Vazquez, L.; Castro, A. 2018: Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson's disease Revista de Neurologia 67(1): 1-5
Arai, M. 2012: Levodopa in combination with carbidopa does not affect plasma arginine vasopressin levels in treatment-naïve older patients with Parkinson's disease: a before-after study Neuro Endocrinology Letters 33(1): 34-36
Gerlach, M.; Desser, H.; Youdim, M.B.; Riederer, P. 1996: New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline Journal of Neural Transmission. Supplementum 48: 7-21
Lökk, J. 2003: Treatment with levodopa can affect latent vitamin B 12 and folic acid deficiency. Patients with Parkinson disease runt the risk of elevated homocysteine levels Lakartidningen 100(35): 2674-2677
Ball, D.E.; Tisocki, K. 1999: Prophylaxis against early anaphylactic reactions to snake antivenom. Stopping trials early may result in insufficient evidence being accrued Bmj 319(7214): 920-921
Vajda, F.J.; Donnan, G.A.; Bladin, P.F. 1978: Patterns of response to levodopa in Parkinson's disease Clinical and Experimental Neurology 15: 299-306